Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach
Carnitine palmitoyltransferase (CPT) catalyzes the transfer of long- and medium-chain fatty acids from cytoplasm into mitochondria, where oxidation of fatty acids takes place. Deficiency of CPT enzyme is associated with rare diseases of fatty acid metabolism. CPT is present in two subforms: CPT I at...
Main Authors: | Pushpa Raj Joshi, Stephan Zierz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/8/1784 |
Similar Items
-
Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency
by: Leila Motlagh Scholle, et al.
Published: (2019-03-01) -
Detection of Early Onset Carnitine Palmitoyltransferase II Deficiency by Newborn Screening: Should CPT II Deficiency Be a Primary Disease Target?
by: Rachel Mador-House, et al.
Published: (2021-08-01) -
Neonatal Carnitine Palmitoyltransferase II Deficiency: A Lethal Entity
by: Sushma Malik, et al.
Published: (2015-10-01) -
Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features
by: Diana Lehmann, et al.
Published: (2017-01-01) -
Acute Respiratory Infection Unveiling CPT II Deficiency
by: Nicolas Blah, et al.
Published: (2018-09-01)